Ares Commercial Real Estate (ACRE) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
21 Nov, 2025Executive summary
Achieved GAAP net income of $9.3 million ($0.17 per share) for Q1 2025, reversing a prior year loss, and distributable earnings of $7.2 million ($0.13 per share).
Increased liquidity and reduced leverage, collecting $307 million in loan repayments, the highest as a percentage of principal in company history.
Declared a $0.15 per share dividend for Q2 2025, yielding over 14% annualized at current stock price.
Book value per share remained stable at $9.88.
No new migrations to risk-rated four or five loans; portfolio fundamentals improved.
Financial highlights
Total revenue for Q1 2025 was $14.9 million, with net interest margin of $9.3 million and interest income of $27.5 million.
Distributable earnings were $7.2 million ($0.13 per share); no realized losses in the quarter.
$307 million in repayments, more than double the prior quarter, reduced borrowings and increased liquidity.
Net debt-to-equity ratio (excluding CECL/CSOL) declined to 1.2x from 1.9x year-over-year.
As of May 2, 2025, available capital was $147 million, including $113 million in cash.
Outlook and guidance
Positioned to accelerate resolution of underperforming assets and selectively originate new loans.
Near-term earnings may vary due to ongoing portfolio repositioning and market volatility.
Expect to begin sales of Brooklyn condo development by year-end 2025 and into 2026.
Management expects primary sources of cash to be sufficient for operating and investing activities for at least the next 12 months.
Will continue to evaluate share buybacks, new investments, and other capital uses.
Latest events from Ares Commercial Real Estate
- Q4 2025 saw a $3.9M net loss, reduced office exposure, and strong liquidity for a 12% yield.ACRE
Q4 202510 Feb 2026 - Q2 2024 net loss of $6.1M, high CECL reserves, and a $0.25 dividend declared.ACRE
Q2 20242 Feb 2026 - Q3 net loss of $5.9M, risk loan reduction, and $0.25 dividend declared.ACRE
Q3 202415 Jan 2026 - Net loss in 2024, but leverage, liquidity, and risk exposure improved.ACRE
Q4 20245 Jan 2026 - Annual meeting to vote on directors, auditor, executive pay, and governance policies.ACRE
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and say-on-pay at the 2025 meeting.ACRE
Proxy Filing1 Dec 2025 - Net loss of $11M, $33M loan loss, but liquidity and new loan activity improved.ACRE
Q2 202523 Nov 2025 - Q3 2025 delivered $5M net income, strong liquidity, and major new loan commitments.ACRE
Q3 202514 Nov 2025